» Articles » PMID: 6326261

Expression Cloning of Human EGF Receptor Complementary DNA: Gene Amplification and Three Related Messenger RNA Products in A431 Cells

Overview
Journal Science
Specialty Science
Date 1984 May 25
PMID 6326261
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

In order to further define the mechanisms by which polypeptide growth factors regulate gene transcription and cellular growth, expression cloning techniques were used to select human epidermal growth factor (EGF) receptor complementary DNA clones. The EGF 3' coding domain shows striking homology to the transforming gene product of avian erythroblastosis virus (v-erbB). Over-expression of EGF receptors in A431 cell lines correlates with increased EGF receptor mRNA levels and amplification (up to 110 times) of the apparently singular EGF receptor gene. There appear to be three cytoplasmic polyadenylated RNA products of EGF receptor gene expression in A431 cells, one of which contains only 5' (EGF binding domain) sequences and is postulated to encode the secreted EGF receptor-related protein.

Citing Articles

From discovery of tyrosine phosphorylation to targeted cancer therapies: The 2018 Tang Prize in Biopharmaceutical Science.

Yu J Biomed J. 2019; 42(2):80-83.

PMID: 31130251 PMC: 6541884. DOI: 10.1016/j.bj.2019.03.004.


AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis.

Tao X, Lu Y, Qiu S, Wang Y, Qin J, Fan Z Cancer Lett. 2017; 408:33-42.

PMID: 28823958 PMC: 5628150. DOI: 10.1016/j.canlet.2017.08.012.


The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR.

Scharaw S, Iskar M, Ori A, Boncompain G, Laketa V, Poser I J Cell Biol. 2016; 215(4):543-558.

PMID: 27872256 PMC: 5119934. DOI: 10.1083/jcb.201601090.


Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance.

Maramotti S, Paci M, Manzotti G, Rapicetta C, Gugnoni M, Galeone C Int J Mol Sci. 2016; 17(4).

PMID: 27104520 PMC: 4849047. DOI: 10.3390/ijms17040593.


Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development.

Schmohl J, Todhunter D, Oh S, Vallera D Toxins (Basel). 2015; 7(10):4067-82.

PMID: 26473923 PMC: 4626721. DOI: 10.3390/toxins7104067.